UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...
BOSTON and LONDON, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) and Axovia Therapeutics Ltd. today announced a joint research collaboration designed to advance the ...
Virax Biolabs partners with Europa Biosite to distribute ImmuneSelect for research use, focusing on T-cell immunity and post-viral syndromes, including Long COVID.
today announced the submission of a Type II Variation to the European MedicinesAgency (EMA) for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR ...
In the UK, ELFBAR and LOST MARY have been advocating for a more robust approach to vape retailing alongside an enhanced regulatory environment, including a retail licensing scheme for vape products, ...
Some results have been hidden because they may be inaccessible to you